Aytu BioScience

AYTU NASDAQ
1.405
-0.015
-1.06%
Closed 16:00 08/20 EDT
Open
1.400
Prev Close
1.420
High
1.425
Low
1.365
Volume
48.55K
Avg Vol (3M)
192.60K
52 Week High
4.800
52 Week Low
0.6800
% Turnover
0.29%
Market Cap
23.16M
1D
5D
1M
3M
1Y
5Y

Related

Webull offers Aytu BioScience AYTU stock price, real time market quotes, professional analyst ratings, and in-depth charts, You can share investing ideas in community to communicate with others and learn trading skills.

Company Profile

Aytu BioScience, Inc. is a commercial-stage healthcare company focused on acquiring, developing and commercializing products in the field of urology. The Company focuses on hypogonadism, prostate cancer, urinary tract infections and male infertility. The Company markets ProstaScint (capromab pendetide), a radio imaging agent indicated to detect the prostate specific membrane antigen (PSMA) in the assessment and staging of prostate cancer. The Company's pipeline includes MiOXSYS, an in vitro diagnostic device. MiOXSYS system is a point-of-care semen analysis system, used for diagnosis and management of male infertility. The Company holds the United States rights to Natesto (testosterone), a formulation of testosterone delivered through a nasal gel. Natesto is used for the treatment of hypogonadism (low testosterone) in men. The Company, through its wholly-owned subsidiary Nuelle, Inc., is focused on women’s sexual wellbeing and intimacy.
MORE >

Recently

Name
Price
%Change